Loading company
Just reported
From Globus Medical's results release of November 5, 2026; its quarterly report has since been filed.
Actual
$763.7M
-0.7% y/y
-3.3% q/q
Guided
—
No guide given
Actual
$1.04
+18% y/y
-5.5% q/q
Guided
—
No guide given
EPS, adjusted: $1.23
Actual
$177.6M
+29% y/y
-2.7% q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Globus Medical is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
MDTMedtronic plc$129.2BA+
SYKStryker Corp.$118.9BA+
EWEdwards Lifesciences Corporation$60.9BA+
GEHCGE Healthcare Technologies Inc.$37BA
GKOSGlaukos Corp$14.6BARose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now AEWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
BIIBBiogen Inc.Oct 28, 2026BAGraded B, now ABuilt from Globus Medical, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
Company outlook: revenue of about $3.1B for Fiscal year 2026 — up 5.1% on a year earlier
Grade B+
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 41 quarters of Globus Medical, Inc.’s grade history. The other 39 go back to November 2016.
